TKI-based regimens remain the primary approach for metastatic renal cell carcinoma after immune checkpoint inhibitor therapy, ...
During a live event, Moshe C. Ornstein, MD, MA, considered the trial design and outcomes of 2 trials of combination regimens ...
Current risk stratification models perform well in assessing recurrence risk in patients with non-clear cell renal cell carcinoma, researchers report.
Dr. Niklas Klümper, resident at the Department of Urology and Pediatric Urology of the University Hospital Bonn (UKB) and working group leader at the Institute for Experimental Oncology (IEO), and Dr.
The 2025 Western Section AUA annual meeting featured a kidney cancer session and a presentation by Jaxson Jeffery discussing the impact of neoadjuvant systemic therapy on tumor and tumor thrombus ...
HIF family transcription factor expression in a cohort of 4362 patients with renal cell carcinoma (RCC). Stratification of the intermediate IMDC risk group according to baseline radiological tumor ...
Sphincter-Sparing Local Excision and Adjuvant Radiation for Anal-Rectal Melanoma PURPOSE: To create a comprehensive algorithm that can predict postoperative renal cell carcinoma (RCC) patient outcomes ...
Throughout October, CURE highlighted research developments and evolving treatment strategies that continue to shape cancer ...
Renal cell carcinoma is the most common form of kidney cancer. It can take time to fully process a diagnosis and what, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback